Company Overview of Galenea Corp.
Galenea Corp., a biopharmaceutical company, engages in developing therapeutics for central nervous system (CNS) diseases. The company focuses on psychiatric disorders, schizophrenia and calcineurin, and obesity and 5-HT2C agonists. Its products include in vitro and in vivo synaptic functional screening and brain slice electrophysiology assays, which include techniques for recording disease-relevant neuronal activity in the prefrontal cortex to measure the effects of drug candidates in animals performing critical memory or cognition-dependent tasks. The company was founded in 2003 and is based in Cambridge, Massachusetts.
300 Technology Square
Cambridge, MA 02139
Founded in 2003
Key Executives for Galenea Corp.
Galenea Corp. Key Developments
Similar Private Companies By Industry
|Unum Therapeutics, Inc.||United States|
|Celliance Corporation||United States|
|Vidus Ocular, Inc.||United States|
|Floragenex, Inc.||United States|
|Nurel Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Galenea Corp., please visit www.galenea.com. Company data is provided by Capital IQ. Please use this form to report any data issues.